CEO Sells Over $5 Million in Company Stock in Discretionary Transactions
LMAT sits 30% above its 52-week low of $78.35.
Summary
George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., sold over $5 million worth of common stock in open market transactions that were not part of a pre-scheduled trading plan.
Key Events · Ownership and Investor Activity · LMAT
-
CEO Sells Significant Shares
George W. LeMaitre, Chairman and CEO, disposed of 46,481 shares of common stock in open market transactions.
-
Over $5 Million in Sales
The shares were sold for a total value of $5,032,413 across two transactions on May 7th and 8th, at prices ranging from $107.64 to $108.69.
-
Discretionary Transaction
The filing explicitly states this was not executed under a Rule 10b5-1 trading plan, indicating a discretionary sale by the CEO.
-
Post-Sale Holdings
Following these transactions, the CEO directly holds 1,430,019 shares of common stock.
Analysis · LMAT · Industrial Applications And Services
This significant open market sale by George W. LeMaitre, the Chairman and CEO, is notable because it was not executed under a pre-planned Rule 10b5-1 trading plan. This indicates a discretionary decision to reduce his direct holdings, which can be interpreted as a lack of conviction at current price levels or a move for personal liquidity, despite the company's recent strong financial performance.
At the time of this filing, LMAT was trading at $101.74 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $78.35 to $118.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.